Mohan Jitendra 4

What Happened

• Mohan Jitendra, CEO of Astera Labs, sold a total of 157,500 shares in open-market transactions on March 17, 2026, generating aggregate proceeds of approximately $20,723,774. The ten reported dispositions ranged in per-lot weighted-average prices from about $125.56 to $134.67 (individual lots and proceeds listed in the filing).
• These were sales (liquidity transactions), not purchases or option exercises. The filing indicates the sales occurred automatically under a Rule 10b5-1 trading plan adopted on December 1, 2025, which is a pre-arranged plan that can make such trades routine.

Key Details

• Transaction date: March 17, 2026 (Form 4 filed March 19, 2026 — appears timely).
• Total shares sold: 157,500; Total proceeds: $20,723,774.
• Per-lot details (from the filing): 8,754 @ $125.56 ($1,099,130); 5,746 @ $126.64 ($727,699); 3,624 @ $127.47 ($461,963); 7,907 @ $128.64 ($1,017,168); 11,120 @ $129.62 ($1,441,332); 13,880 @ $130.74 ($1,814,685); 22,766 @ $131.61 ($2,996,236); 43,289 @ $132.72 ($5,745,377); 22,309 @ $133.66 ($2,981,915); 18,105 @ $134.67 ($2,438,269).
• Several transactions report weighted-average prices with footnote ranges (the filer offers to provide per-price breakdowns on request — see footnotes F2–F12).
• Footnotes note that some shares referenced in the filing are held in various estate/living trusts (F3, F13–F17) and that the reporting person disclaims beneficial ownership of those trust-held shares except for any pecuniary interest.
• Filing timeliness: The report was filed two days after the trades (generally within the Section 16 reporting window), so no late-file indication was included.

Context

• Sales made pursuant to a Rule 10b5-1 plan are often automatic and pre-scheduled, which can reduce implication about the insider’s view of the company; sales alone are less informative than purchases about management sentiment.
• For retail investors, note this is insider selling for liquidity under a prearranged plan — not an option exercise or a gift. If you want the exact number of shares sold at each individual price within the ranges cited, the reporting person has offered to provide that breakdown upon request to the issuer, shareholders, or the SEC staff.